Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm
Clinical trial NCT02454283 · TERMINATED
Trial details
- NCT number
- NCT02454283
- Sponsor
- Laguna Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2015-11-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.